Fibrous Dysplasia is an uncommon chronic bone disorder in which fibrous tissue develops in place of normal bone, making the bone weaker and more susceptible to fracturing. Some medications are currently prescribed to decrease the activity of cells that result in dissolving bone, and sometimes surgical treatment is necessary in order to halt the progression of the disorder. The weakened area of bone and the expansion of fibrous tissue causes patients severe pain, and cannabis can reduce these symptoms thanks to its analgesic properties.
Both THC and CBD effectively lower acute and chronic pain by activating CB1 and CB2 receptors that release neurotransmitters and central nervous system immune cells that manage pain levels. Cannabis not only lowers neuropathic and nociceptive pain levels, but is also effective in managing treatment-resistant pain. In addition, some studies have found cannabis is extremely effective in promoting bone health and facilitating bone healing after fractures. Because fibrous dysplasia is an uncommon disease, along with cannabis' status as a Schedule I drug, there is a general lack of information regarding the use of cannabis for treating this disorder. If you are using medical marijuana to treat your fibrous dysplasia and/or pain symptoms, please journal on a daily basis! We can use the anonymous information we collect to enhance our understanding of medical cannabis and its many applications, allowing us to create and offer accurate guidelines for medical professionals and patients when it comes to creating effective mmj dosing regimens.
This information has been brought to you in part by Medical Marijuana Inc. and approved by our Chief Medical Officer.